Clinical Research
corporate_fare

Sun Pharmaceutical Industries Inc.

Address
99 Hayden Avenue Suite 400

Sponsor Overview

assignment
1
sponsored trial
science
0
molecules
location_city
1
research centre
public
1
country
person_search
1
investigator

Specializations

Dermatology and Autoimmune Hair Disorders

Clinical research activity is centered on alopecia areata, a condition involving immune-mediated disruption of hair growth and loss. The sponsor’s trial portfolio reflects interest in therapies directed at restoring hair follicle function and addressing the underlying inflammatory process associated with this disorder.

  • Alopecia areata
  • Hair loss disorders
  • Immune-mediated dermatologic disease

Current research interest is focused on therapeutic approaches relevant to scalp and follicular disease, with attention to treatment areas in dermatologic autoimmunity.

Immunology and Inflammatory Signaling

The sponsor’s research landscape includes medicines aimed at modulating immune pathways involved in inflammatory disease. This aligns with therapeutic development for conditions where immune dysregulation contributes to tissue-specific damage and chronic symptoms.

  • Immune pathway modulation
  • Inflammatory disease
  • Autoimmune mechanisms

Interest in immune-targeted treatment extends to disorders where controlling pathological signaling is central to clinical benefit.

Clinical Pharmacology and Drug Safety

Research activity also covers early clinical evaluation of investigational therapies, with emphasis on safety, tolerability, and pharmacokinetics. These areas support the development of oral and systemic treatments intended for immune-related conditions.

  • Safety assessment
  • Tolerability
  • Pharmacokinetics and pharmacodynamics

The sponsor’s therapeutic interest includes characterizing how candidate medicines behave in the body and how they influence biological targets relevant to disease control.

Sponsored Trials

Trial Name Country Status
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Deuruxolitinib in Healthy AdultsRomania RomaniaRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 1 sites collaborated multiple times

This sponsor has worked with 1 site across their trial portfolio.

Therapeutic Focus

  • 1.
    Immune System Diseases1 trial
    322 other sponsors

Partnered Research Centres

1 centre
location_city
assignment38
Terapia S.A.
Address
Strada Fabricii Nr. 124, 400640 Cluj Napoca
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Sun Pharmaceutical Industries Inc..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.